Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis.
BDNF
CREB
NGF
amyloidosis
miR-150-5p
microRNAs
transthyretin
Journal
Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914
Informations de publication
Date de publication:
2020
2020
Historique:
received:
08
03
2020
accepted:
12
05
2020
entrez:
14
7
2020
pubmed:
14
7
2020
medline:
14
7
2020
Statut:
epublish
Résumé
Transthyretin variant amyloidosis (ATTRv) is a rare autosomal dominant disease characterized by the accumulation of amyloid in many organs, mostly causing a sensory-motor neuropathy, cardiomyopathy, and dysautonomia. The aim of the study was to report microRNAs (miRNAs) expression profile identified in the blood of ATTRv patients. Ten ATTRv patients, 10 asymptomatic carriers of transthyretin variant (TTRv), 10 patients with Charcot-Marie-Tooth (CMT) disease, and 10 healthy controls were studied. Human Schwann cells cultures were used to study the regulatory effects of miR-150-5p on the expression of cAMP response element-binding protein (CREB), brain-derived neurotrophic factor (BDNF), and nerve growth factor (NGF). ATTRv patients had 33 miRNAs up-regulated and 48 down-regulated versus healthy controls; 9 miRNAs were up-regulated and 30 down-regulated versus CMT patients; 19 miRNAs were up-regulated and 38 down-regulated versus asymptomatic TTRv carriers. Twelve out of the 19 upregulated miRNAs had a fold increase higher than 100. The validation experiment indicated miR-150-5p as a valuable biomarker to differentiate ATTRv patients from asymptomatic TTRv carriers (AUC: 0.9728;
Identifiants
pubmed: 32655365
doi: 10.3389/fnmol.2020.00102
pmc: PMC7325132
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102Informations de copyright
Copyright © 2020 Vita, Aguennouz, Polito, Oteri, Russo, Gentile, Barbagallo, Ragusa, Rodolico, Di Giorgio, Toscano, Vita and Mazzeo.
Références
J Nucl Cardiol. 2019 Nov 18;:
pubmed: 31741327
Eur J Neurol. 2019 Jan;26(1):94-e10
pubmed: 30102818
Nature. 2011 Oct 19;478(7369):404-7
pubmed: 22012398
BMC Neurol. 2019 Jun 28;19(1):146
pubmed: 31253122
Nucleic Acids Res. 2016 May 5;44(8):3865-77
pubmed: 26921406
Curr Neuropharmacol. 2015;13(3):294-303
pubmed: 26411962
Mol Cell Neurosci. 2016 Mar;71:13-24
pubmed: 26658803
Lancet Oncol. 2012 Jun;13(6):e249-58
pubmed: 22652233
Amyloid. 2014 Mar;21(1):35-44
pubmed: 24455993
PLoS One. 2018 Oct 10;13(10):e0205514
pubmed: 30304034
J Clin Invest. 2012 Mar;122(3):1097-108
pubmed: 22326957
Cell J. 2020 Apr;22(1):92-95
pubmed: 31606972
Neural Regen Res. 2017 Apr;12(4):518-524
pubmed: 28553320
Brain Res Bull. 1976 Jul-Aug;1(4):393-412
pubmed: 61795
Curr Opin Neurol. 2017 Oct;30(5):481-489
pubmed: 28678039
PLoS One. 2015 Oct 01;10(10):e0139233
pubmed: 26426747
Life Sci. 2019 Sep 1;232:116651
pubmed: 31302195
FASEB J. 2011 May;25(5):1544-55
pubmed: 21248242
Nat Rev Neurol. 2019 Jul;15(7):387-404
pubmed: 31209302
Oncotarget. 2016 Jun 7;7(23):33627-48
pubmed: 27144524
J Neurochem. 2011 Jan;116(1):1-9
pubmed: 21044077
Brain Behav Immun. 2019 May;78:9-20
pubmed: 30641141
Immunol Lett. 2016 Apr;172:1-10
pubmed: 26549736
Cancer Med. 2017 Jan;6(1):109-119
pubmed: 28035762
Curr Opin Neurol. 2016 Feb;29 Suppl 1:S14-26
pubmed: 26734952
Ind Health. 2015;53(1):38-47
pubmed: 25224332
PLoS Pathog. 2012;8(11):e1003002
pubmed: 23144617
Front Physiol. 2019 Apr 26;10:455
pubmed: 31105581
Front Pharmacol. 2014 Mar 12;5:36
pubmed: 24659967
Cancer Cell. 2012 Oct 16;22(4):524-35
pubmed: 23079661
Pharmacol Res. 2019 Oct;148:104458
pubmed: 31546015
Alzheimers Dement (Amst). 2015 Jun 1;1(2):187-193
pubmed: 26207261
JACC Cardiovasc Imaging. 2014 May;7(5):511-4
pubmed: 24831211
Neurol Sci. 2019 Apr;40(4):661-669
pubmed: 30847674
Amyloid. 2018 Dec;25(4):242-246
pubmed: 30638075
Pharmacol Res. 2011 Apr;63(4):266-77
pubmed: 21195180
PLoS One. 2018 Oct 17;13(10):e0204235
pubmed: 30332417
Nature. 2011 Dec 14;481(7380):190-4
pubmed: 22170610
J Biol Chem. 2019 Mar 8;294(10):3489-3500
pubmed: 30626732
J Neuromuscul Dis. 2015 Jul 22;2(s2):S39-S48
pubmed: 27858761
Front Mol Neurosci. 2018 Aug 20;11:290
pubmed: 30177873
Biochem Biophys Res Commun. 2010 Feb 12;392(3):340-5
pubmed: 20067763
Neurobiol Dis. 2013 Jun;54:456-63
pubmed: 23376683
J Hum Genet. 2017 Jan;62(1):105-112
pubmed: 27412874
J Heart Lung Transplant. 2017 Jun;36(6):616-624
pubmed: 28259597
Basic Res Cardiol. 2018 Aug 9;113(5):37
pubmed: 30094473
Nat Immunol. 2008 Aug;9(8):839-45
pubmed: 18645592
Curr Opin Neurol. 2016 Feb;29 Suppl 1:S27-35
pubmed: 26734953
J Nucl Cardiol. 2018 Oct 29;:
pubmed: 30374850
Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1344-1350
pubmed: 28159995